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Introduction
In the past decade increasing attention has been given to
the study of migraine. Migraine is a recurring headache
disorder manifest in attacks lasting 4–72 h and affecting
about 10% of the general population. Migraine is clinical-
ly distinguishable as two main types: migraine with aura
(MA) and migraine without aura (MO), i.e., with or with-
out the complex of focal neurological symptoms (sco-
tomas, scintillations, fortification spectra, etc.) that initi-
ates or accompanies pain attacks [1].
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Abstract Migraine without aura
(MO) and migraine with aura (MA)
are disorders involving multiple
environmental and genetic factors.
The A/G polymorphism located
within exon 1 of the gene encoding
the cytotoxic T lymphocyte antigen
4 (CTLA-4) is associated with sev-
eral HLA-associated multifactorial
diseases. The CTLA-4 family
shows a negative control on T-cell
proliferation and cytokine produc-
tion (TNF-α and IL-10). In the pre-
sent study we investigated the con-
tribution of the candidate gene
CTLA-4 in migraine pathophysiolo-
gy. Included in the study were 96
MO and 39 MA migraine patients
and 106 healthy individuals as con-
trol group. The results showed no
statistical difference of allele fre-
quencies between patient group and
control group. These results would
indicate no association between
MA and MO migraine and CTLA-4
polymorphism, excluding any pos-
sible role of the CTLA-4 gene as a
genetic factor determining suscepti-
bility to migraine.
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The two types of migraine involve multiple environ-
mental and genetic factors. Several studies on familial
hemiplegic migraine (FHM), a rare autosomal dominant
subtype of MA, identified the responsible genes on chro-
mosome 19 and chromosome 1 [2]. In two previous stud-
ies, we hypothesised both a protective role for the HLA-
DR2 antigen, providing an additional basis for the pro-
posed genetic heterogeneity between migraine without
aura and migraine with aura, and involvement of lympho-
toxin a (TNF-β) as a susceptibility gene in migraine with-
out aura [3, 4]. The A/G polymorphism located within
exon 1 at position 49 of the gene encoding the cytotoxic T
lymphocyte antigen 4 (CTLA-4) is associated with several
multifactorial HLA-associated diseases such as type 1 dia-
betes, inflammatory bowel diseases, etc. The CTLA-4
family shows a negative control on T-cell proliferation and
cytokine production (TNF-α and IL-10) [5, 6]. In the pre-
sent study we searched for an association between
migraine and the gene encoding CTLA-4.
Material and methods
Patients and controls
A controlled study was done in 135 migraine patients: 39 with
MA (9 males, 30 females, mean age 39.7±7.4) and 96 with MO
(21 males, 75 females, mean age 36.7±6.9) diagnosed according
to the 2004 International Headache Society (IHS) criteria. One
hundred and six unrelated healthy and migraine-free subjects
from the same geographic area (Central Italy), randomly select-
ed, were used as controls. The study protocol was approved by
our institutional ethics board and informed consent was obtained
from all patients and from controls. The recommended principles
of the Declaration of Helsinki, September 1989, were closely
observed during this clinical research study.
Methods
Genomic DNA was isolated from proteinase-K-treated periph-
eral blood leukocytes according to the salting-out method. The
PCR-RFLP BstEII polymorphism of the CTLA-4 gene was
studied by PCR amplification using specific primers previously
described by Marron et al. [5] of a 152-bp fragment in the first
exon of the gene, subsequently digested by BstEII restriction
enzyme. The presence or absence of the restriction site defines
two alleles: CTLA-4 A results in a cleaved fragment of 130 bp
and CTLA-4 G allele yields an intact 152-bp fragment.
Digested products were separated by electrophoresis on 3.5%
agarose gel.
Statistics
CTLA-4 allele frequencies were estimated by direct counting in
patients and controls. The frequencies of alleles or genotypes of
patients and controls were compared by chi-square contingency
table analysis. Differences were considered statistically signifi-
cant when p was less than 0.05. Hardy-Weinberg equilibrium at
CTLA-4 locus was verified in patients and control populations.
Results
Allele distribution of the studied polymorphism is in
Hardy-Weinberg equilibrium in both controls and patients
(data not shown). No significant CTLA-4 associations
either with MO or with MA were found and when we
compared the whole group of patients with controls
(Tables 1, 2). The distribution of CTLA-4 genotypes in
migraine patients and controls are shown in Table 3. No
significant differences were observed between patients
and controls.
Table 1 CTLA-4 allele frequencies in MA and MO patients and controls
CTLA-4 alleles Controls (n=106) MA (n=39) MO (n=96)
n Frequency n Frequency n Frequency
A 150 0.7075 51 0.6538 121 0.6302
G 62 0.2925 27 0.3462 71 0.3698
Table 2 CTLA-4 allele frequencies in migraine and controls
CTLA-4 alleles Controls (n=106) Patients (n=135)
n Frequency n Frequency
A 150 0.7075 172 0.6370
G 62 0.2925 98 0.3630
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Discussion
In previous studies, we observed an involvement of the
HLA polymorphism and TNF-β in susceptibility to
migraine. In addition we have to look for other suscepti-
bility candidate genes located either in the same region or
on other chromosomes. The region 2q33, where the
CTLA-4 gene is located, is considered to be associated
with several multifactorial diseases.
To the best of our knowledge, this study is the largest
ever conducted on the relationship between migraine sub-
jects and CTLA-4 49 A>G polymorphism in the Italian
population. It indicates that there is no association between
migraine and CTLA-4 polymorphism. This suggests that
CTLA-4 polymorphism does not impact on the risk of
developing of migraine. As several genetic factors are
involved in multifactorial diseases, further studies are
needed to identify other genes responsible for genetic sus-
ceptibility in migraine.
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Table 3 Distribution of CTLA-4 genotypes in MA and MO patients and controls
CTLA-4 alleles Controls (n=106) MA (n=39) MO (n=96)
n Frequency n Frequency n Frequency
A-A 51 0.481 14 0.359 35 0.365
A-G 48 0.453 23 0.590 51 0.531
G-G 7 0.066 2 0.051 10 0.104
